Product Description
Repotrectinib is a synthetic small molecule tyrosine kinase inhibitor compound, specially developed for in-vitro oncology pharmacology mechanism research. It owns characteristic fused heterocyclic sequence structure features, widely adopted to prepare in-vitro test solutions for ROS1 and NTRK kinase related cell model experiments. Researchers utilize this raw material for kinase receptor binding mechanism exploration, tumor cell proliferation inhibition cell model setup, compound stability assessment and targeted drug intermediate feasibility validation.
Under standard lab cold-storage operating conditions, this high-purity crystalline powder delivers stable dissolution performance after reconstitution. It maintains stable chemical properties in prepared DMSO aqueous test solution systems, providing reliable raw reference material for in-vitro kinase binding simulation and compound degradation research. It fits perfectly for targeted drug formulation pre-study and small molecule molecular modification exploration.

COA
| Items | Specifications |
|---|---|
| Appearance | White powder |
| Loss on Drying | ≤2.0% |
| Residue on Ignition | ≥0.5% |
| Lead | ≤1 ppm |
| Arsenic | ≤1 ppm |
| Cadmium | ≤1 ppm |
| Mercury | ≤0.1 ppm |
| Total Aerobic Count | ≤1000 CFU/g |
| Yeast & Mold | ≤100 CFU/g |
| E.Coli, Salmonella | Negative |
| Shelf Life | 24 months (sealed and stored away from light) |
Functions and Effects
◆ ROS1 / NTRK Kinase Inhibition In-vitro Research
Functions as in-vitro pharmacological additive for cell incubation systems, simulates tyrosine kinase receptor inhibition effect during oncology related pharmacological test assays.
◆ Small Molecule Kinase Inhibitor Hydrolysis Stability Evaluation
Acts as standard reference substance to observe molecular hydrolysis and oxidative degradation responses under varied pH, temperature in cell-free liquid reaction systems.
◆ Targeted Drug Heterocyclic Scaffold Building-Block
Provides active heterocyclic containing molecular skeleton for laboratory organic synthesis, supporting derivative molecule structural modification exploration.
◆ DMSO Buffer Reconstitution Matching Performance
Easy to dissolve in DMSO medium, can be compounded with physiological simulation salts to prepare multi-component in-vitro tumor cell pharmacological working solutions.

Application Fields

◆ In-vitro Tumor Targeted Pharmacology Mechanism Research
Lab-scale reference reagent for preparing cell incubation working solutions used in kinase inhibitor pharmacological screening, supporting repeated solution formula screening for targeted anti-tumor drug research workflows.
◆ Targeted Anti-tumor Drug Formulation Pre-Study
Applied in lab-scale formulation development of oral targeted preparations, acting as core active raw material for exploring new small molecule oral delivery backbones.
◆ Small Molecule Drug Impurity & Analytical Method Validation
High-purity reference standard for drug impurity detection verification, thermal stability comparison experiment validation and pharmaceutical small molecule solution benchmark testing.
Business Scope

Packaging And Transportation Methods

Certificationss

FAQ
Our address
No. 56, Jinye 1st Road, Hi-Tech Zone, Xi'an,Shaanxi Province, China
Phone Number
18192393517
dennis04@xaltbio.com

Hot Tags: repotrectinib, China repotrectinib manufacturers, suppliers, factory, Amlodipine Powder, Azithromycin Dihydrate Powder, Cyproheptadine Hydrochloride Powder, Meloxicam Powder, Metformin Powder CAS 1115 70 4, Valproic Acid Powder